Extract

The objective of this study is to determine the comparative efficacy and safety of two oral regimens of dabigatran etexilate, compared to a standard subcutaneous regimen of enoxaparin, in prevention of venous thromboembolism in patients with primary elective total hip replacement surgery.

Inclusion criteria

• Thromboembolism ,Arthroplasty, Replacement, Hip

Country

• Australia
• Austria
• Belgium
• Czech Republic
• Denmark
• Finland
• France
• Germany
• Hungary
• Italy
• Netherlands
• Norway
• Poland
• South Africa
• Spain
• Sweden

Links

• nct
• ictrp